VLamax measures an athlete’s maximum glycolytic (anaerobic) energy production. As with every molecule of lactate which is produced there is a certain amount of energy (ATP) produced with it, lactate production rate is a valid marker for glycolytic energy production rate.
VLamax can be thought of as the anaerobic glycolytic counterpart to VO₂max: while VO₂max reflects maximum aerobic energy production, VLamax reflects maximum glycolytic energy production.
From national federations and Olympic programmes to WorldTour teams and professional clubs worldwide.
VLamax correlates directly with sprint performance. A low VLamax of approximately 0.2–0.3 mmol/L/s, as found in professional marathon runners and triathletes depending on body weight and body composition, contributes approximately 150–300 watts of power output during a 15–20 second sprint. In contrast, a VLamax of around 1.0 mmol/L/s, as found in pure sprinters, can contribute approximately 1000 watts during the same effort. This illustrates the importance of VLamax: it directly correlates with sprint power or sprint speed.
If the goal is to improve sprint performance, measuring VLamax is needed to determine whether there is room to increase glycolytic power, and therefore sprint power or speed.
Endurance athleteVLamax ≈ 0.2–0.3 mmol/L/s
SprinterVLamax ≈ 1.0 mmol/L/sApproximate glycolytic power contribution during a 15–20 second sprint
Thresholds such as LT1, LT2, and maximal lactate steady state (MLSS) are central metrics in endurance sports. MLSS represents the equilibrium between lactate production and combustion, and lactate production is heavily linked to VLamax. With all other metrics being equal, a higher VLamax leads to a lower speed/power at MLSS because more lactate is produced.
If the goal is to increase threshold power or speed, VLamax must be known to determine whether reducing glycolytic activity can further improve threshold performance.
The lactate profile curve of a conventional incremental test is highly influenced by VLamax. A higher VLamax means greater lactate production and therefore shifts the lactate curve to the left, while a lower VLamax results in less lactate production and shifts the curve to the right. Consequently, a left or right shift of the lactate profile does not necessarily indicate a change in aerobic capacity or aerobic performance, it may instead result from a change in anaerobic, more precisely glycolytic, performance.
Therefore, interpreting differences in lactate profiles between two athletes, or changes in the same athlete before and after a training program, is not valid without knowing VLamax.
VLamax is a measure of lactate production, and as one molecule of glucose creates two molecules of lactate, there is a direct proportional link between lactate production and carbohydrate utilization rate. Therefore a higher VLamax results in greater carbohydrate utilization and, consequently, lower fat combustion rate.
VLamax is therefore not only important for sprinters, but especially relevant for endurance athletes.
With a higher VLamax the gross lactate production at low intensities is increased. Thereby reducing the ability to clear high lactate concentration, which for example have been accumulated during bouts of high intensity, during recovery phases in training and competition.
Therefore, in sports where repeated high-intensity efforts and recovery between them are critical, such as cycling, football or basketball, knowing VLamax is important for understanding how quickly, and at what speed or power, an athlete can recover.
In 2003, INSCYD founder Sebastian Weber developed the first protocol applying this approach on a cycling ergometer.
The principle seemed straightforward: measure blood lactate before and after a maximal sprint and divide the increase in lactate concentration (Δlactate) by the effective glycolytic time. This effective time was calculated as sprint duration minus an assumed “alactic time”, the initial part of the sprint during which energy production was considered to come predominantly from creatine phosphate rather than glycolysis.

The problem with this approach is that several assumptions required by the equation do not accurately represent what happens physiologically during and after a sprint.
Most importantly, the concept of a fixed “alactic time” is problematic in itself. Glycolytic energy production does not simply switch on after a predefined number of seconds. Its contribution depends on both exercise duration and intensity, which depends on the ability of the athlete to accelerate against a load.
Training can change acceleration, sprint power, muscle mass and creatine phosphate availability, all of which will change the relative contribution of energy from glycolysis and creatine phosphates during such a sprint. As a result, the physiologically appropriate “alactic time” changes from one test to the next, even when the equation continues to assume the same fixed value. This means that even test-retest comparisons based on a fixed alactic time can systematically misrepresent changes in VLamax.
Further limitations include lactate distribution and combustion, the offset of glycolytic flux after the sprint and body composition.
Together, these factors mean that Δlactate / Δtime cannot be treated as a direct measurement of maximal glycolytic energy production.
This is why even the founder of INSCYD, who developed the first ever sprint testing method for VLamax, ditched this method entirely.
Today, VLamax can be assessed from an approximately 20-second maximal sprint without measuring blood lactate. Instead of using Δlactate and an assumed alactic time, INSCYD models the contribution of the different energy systems throughout the sprint, accounting for factors such as body composition and muscle mass.
The longer sprint allows the glycolytic rate to reach its maximum and begin to decline, confirming that peak VLamax has been reached, similar to identifying a plateau in a VO₂max test. Because the calculation does not rely on a fixed alactic time or post-exercise lactate, differences in acceleration, power development, test setup or changes through training do not introduce the same methodological limitations.

More practically, VLamax can be determined from submaximal endurance tests that are already part of an athlete’s testing routine, without requiring a separate sprint test. As explained above, VLamax directly influences the lactate concentrations measured during submaximal exercise. When other relevant factors, such as body composition, are accounted for, the measured lactate concentration allows to calculate the actual lactate production rate and thereby VLamax.
The resulting VLamax can also reproduce the athlete’s glycolytic contribution during sprint efforts. This approach eliminates the need for a separate testing protocol and allows VLamax to be integrated into existing testing procedures across different sports.

VLamax provides essential context for interpreting sprint performance, thresholds and lactate profiles, substrate utilization, and recovery from high-intensity efforts. Whether the goal is to improve sprint power, understand changes in an incremental lactate test, optimize FatMax and carbohydrate utilization, or improve threshold performance, knowing VLamax helps explain why an athlete responds the way they do.
With INSCYD, measuring VLamax does not require changing your existing testing workflow. If you already collect sprint or power-duration data, VLamax can be determined from maximal efforts. If you perform incremental or other submaximal tests with lactate measurements, VLamax can be derived from those as well. You can keep the tests, protocols and equipment you already use, and add VLamax to the physiological information you get from them.
Where lactate production and combustion balance: the highest sustainable intensity.
Read more Fat Combustion RateHow much fat an athlete burns at every intensity, in kcal/h.
Read more Recovery IndexHow quickly an athlete is ready for the next high-intensity effort, and what drives it.
Read moreVO₂max, VLamax, FatMax, thresholds, fuel use and training zones, from a single test in the lab, in the field or fully remote.